What is the level of liabilities of Cryosite this year?
Cryosite has a debt balance of 18.26 M AUD this year.
Cryosite Liabilities 2025
Cryosite Liabilities
18.26 M AUD
Ticker
CTE.AX
ISIN
AU000000CTE1
WKN
621943
In 2025, Cryosite's total liabilities amounted to 18.26 M AUD, a -8.06% difference from the 19.86 M AUD total liabilities in the previous year.
Cryosite Aktienanalyse
What does Cryosite do?
Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Cryosite's Liabilities
Cryosite's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cryosite's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Cryosite's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Cryosite's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Cryosite’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Cryosite stock
What were the liabilities of Cryosite compared to the previous year?
The liabilities of Cryosite have increased by -8.06% dropped compared to the previous year.
What are the consequences of high debt for investors of Cryosite?
High liabilities can pose a risk for investors of Cryosite, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Cryosite?
Low liabilities mean that Cryosite has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Cryosite affect the company?
An increase in liabilities of Cryosite can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Cryosite affect the company?
A decrease in the liabilities of Cryosite can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Cryosite?
Some factors that can influence the liabilities of Cryosite include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Cryosite so important for investors?
The liabilities of Cryosite are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Cryosite take to modify the liabilities?
To change its liabilities, Cryosite can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Cryosite pay?
Over the past 12 months, Cryosite paid a dividend of 0.02 AUD . This corresponds to a dividend yield of about 1.92 %. For the coming 12 months, Cryosite is expected to pay a dividend of 0.02 AUD.
What is the dividend yield of Cryosite?
The current dividend yield of Cryosite is 1.92 %.
When does Cryosite pay dividends?
Cryosite pays a quarterly dividend. This is distributed in the months of October, October, March, October.
How secure is the dividend of Cryosite?
Cryosite paid dividends every year for the past 2 years.
What is the dividend of Cryosite?
For the upcoming 12 months, dividends amounting to 0.02 AUD are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Cryosite located?
Cryosite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cryosite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cryosite from 10/10/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Cryosite pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cryosite in the year 2024?
In the year 2024, Cryosite distributed 0.01 AUD as dividends.
In which currency does Cryosite pay out the dividend?
The dividends of Cryosite are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cryosite
Our stock analysis for Cryosite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryosite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
